|
|
Volumn 16, Issue SUPPL. N, 1995, Pages 107-110
|
|
ACE inhibitor co-therapy in patients with heart failure: Rationale for the Randomized Aldactone Evaluation Study (RALES)
|
|
Author keywords
Aldosterone escape; Angiotensin converting enzyme inhibitors; Heart failure; RALES; Spironolactone; Systolic left ventricular dysfunction
|
|
Indexed keywords
ALDOSTERONE;
ALDOSTERONE ANTAGONIST;
ATRIAL NATRIURETIC FACTOR;
CORTICOTROPIN;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOOP DIURETIC AGENT;
POTASSIUM;
RENIN;
SPIRONOLACTONE;
ALDOSTERONE URINE LEVEL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIURESIS;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HUMAN;
PLASMA RENIN ACTIVITY;
POTASSIUM BLOOD LEVEL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
|
|
EID: 0029550133
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1093/eurheartj/16.suppl_n.107 Document Type: Conference Paper |
|
Times cited : (73)
|
|
References (0)
|
